Prostemics Co. Ltd (203690) — Capital Reinvestment Ratio

Latest as of December 2021: 5.52x

Prostemics Co. Ltd (203690) has a Capital Reinvestment Ratio of 5.52x as of December 2021, meaning it reinvests 6% of its operating cash flow (₩3.13 Billion) in capital expenditures (₩17.30 Billion). See 203690 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

5.52x
Capex / Operating Cash Flow

Operating Cash Flow

₩3.13 Billion
KRW

Capital Expenditures

₩17.30 Billion
KRW

Data as of

Dec 2021
Most recent filing

Prostemics Co. Ltd Capital Reinvestment Ratio (2015–2021)

This chart tracks Prostemics Co. Ltd's Capital Reinvestment Ratio across 3 annual periods. See 203690 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.

Annual Capital Reinvestment Ratio for Prostemics Co. Ltd (2015–2021)

Year-by-year Capital Reinvestment Ratio for Prostemics Co. Ltd from 2015 to 2021. For the full cash flow conversion analysis, see Prostemics Co. Ltd (203690) cash flow conversion.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2021 5.76x ₩3.00 Billion ₩17.30 Billion ▲ +474.9%
2016 1.00x ₩5.86 Billion ₩5.87 Billion ▼ -12.1%
2015 1.14x ₩6.25 Billion ₩7.12 Billion —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow